This event has passed.
Vendor Show
January 27 @ 8:00 am - 5:00 pm
The Delaware Valley Drug Metabolism: Vendor Show on Jan 27, 202620 vendors, 11 scientific presentations!
Registration fees:
Regular: $25
Retirees and students: Free
Confirmed vendors:
Aliri Bioanalysis, Alturas Analytics, BioIVT, Charles River, Cyprotex,
Discovery Life Sciences, Diteba, Frontage, Hypha, Inotiv, Labcorp,
LabLogic Systems, Meadowhawk, Medicilon, Pharmaron,
QPS, QRD Pharma, Resolian, Shimadzu, Waters
Schedule
7:30 – 8:30 AM
Registration, continental breakfast, networking, visit vendor exhibits
8:40 – 9:05 AM
Hepatocyte spheroids to improve duration of drug metabolism assays
Erik Willems, DLS
9:05 – 9:30 AM
PK/TK strategy in drug development: optimizing design, execution, and data integrity
Ryan Schmich, Alturas
9:30 – 9:55 AM
Investigating drug metabolism of methapyrilene in a rat model using the Xevo MRT mass spectrometer
Aurelie Marcotte, Waters
9:55 – 10:25 AM
Coffee break, networking, visit vendor exhibits
10:25 – 10:50 AM
In vitro plasma protein binding assessment for highly protein-bound compounds under the ICH M12 guideline
Nan Zhao, Resolian
10:50 – 11:15 AM
Addressing challenges in drug metabolite synthesis: case studies from discovery and development
Liam Evans, Hypha
11:15 – 11:40 AM
Validation of low energy accelerator mass spectrometer and opportunities to increase industry utilization
Stephen English, Pharmaron
11:40 – 1:10 PM
Lunch (included), networking, visit vendor exhibits
1:10 – 1:35 PM
Transporting your way through the BBB and around the CNS
Mark Warren, BioIVT
1:35 – 2:00 PM
Are in vitro DDI studies needed for oligonucleotide therapeutics?
Zamas Lam, QPS
2:00 – 2:25 PM
Radiopharmaceuticals and drug development: DMPK considerations and workstreams
Sarah Wills, Labcorp
2:25 – 2:50 PM
Coffee break, networking, visit vendor exhibits
2:50 – 3:15 PM
An automated high-throughput 384-well ADME screening workflow on the SCIEX 7600 ZenoTOF for AI-driven drug discovery
Li Li, Cyprotex
3:15 – 3:40 PM
Utility of a humanized liver chimeric mouse model to investigate acute obstructive nephropathy by an insoluble metabolite
J. Matthew Hutzler, Inotiv